| Literature DB >> 28989842 |
Kazuyoshi Kobayashi1, Shiro Imagama1, Kei Ando1, Naoki Ishiguro1, Masaomi Yamashita2, Yawara Eguchi3, Morio Matsumoto4, Ken Ishii4, Tomohiro Hikata4, Shoji Seki5, Hidetomi Terai6, Akinobu Suzuki6, Koji Tamai6, Masaaki Aramomi7, Tetsuhiro Ishikawa7, Atsushi Kimura8, Hirokazu Inoue8, Gen Inoue9, Masayuki Miyagi9, Wataru Saito9, Kei Yamada10, Michio Hongo11, Hirosuke Nishimura12, Hidekazu Suzuki12, Atsushi Nakano13, Kazuyuki Watanabe14, Hirotaka Chikuda15, Junichi Ohya15, Yasuchika Aoki16, Masayuki Shimizu17, Toshimasa Futatsugi17, Keijiro Mukaiyama17, Masaichi Hasegawa18, Katsuhito Kiyasu19, Haku Iizuka20, Yoichi Iizuka20, Ryoichi Kobayashi20, Kotaro Nishida21, Kenichiro Kakutani21, Hideaki Nakajima22, Hideki Murakami23, Satoru Demura23, Satoshi Kato23, Katsuhito Yoshioka23, Takashi Namikawa24, Kei Watanabe25,26, Kazuyoshi Nakanishi27, Yukihiro Nakagawa28, Mitsunori Yoshimoto29, Hiroyasu Fujiwara30, Norihiro Nishida31, Yasuaki Imajo31, Masashi Yamazaki32, Masataka Sakane32, Tetsuya Abe32, Kengo Fujii32, Takashi Kaito33, Takeo Furuya34, Sumihisa Orita34, Seiji Ohtori34.
Abstract
STUDYEntities:
Keywords: complications; elderly; risk factor; spine surgery
Year: 2017 PMID: 28989842 PMCID: PMC5624380 DOI: 10.1177/2192568217716144
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Characteristics of the 262 Cases.
| Item | Value (Range) |
|---|---|
| Demographic | |
| Age (years) | 83 (80-91) |
| Sex, male/female (n/n) | 122/140 |
| Previous spinal surgery (n) | 47 |
| Body mass index (kg/m2) | 23.3 (14-33) |
| Disease duration (years) | 3.6 (0.1-55) |
| Smoking status (n) | 4 |
| Drug use | |
| Nonsteroidal anti-inflammatory drugs (NSAIDs) | 122 |
| Opioids | 18 |
| Osteoporosis agents | 68 |
| Anticoagulants | 58 |
| Comorbidity | |
| Hypertension | 107 |
| Preexisting neoplasm | 45 |
| Diabetes | 40 |
| Cerebrovascular disease | 20 |
| Operative factor | |
| Operative time (minutes) | 171 (34-615) |
| Estimated blood loss (mL) | 289 (5-6500) |
| Fusion with instrumentation (n) | 87 |
Figure 1.Bar graph showing the population stratified by age.
Diseases and Lesions in 262 Cases.
| Disease and surgical lesion | n (%) |
|---|---|
| LSCS (lumbar spondylosis) | 132 (50) |
| Cervical spondylotic myelopathy | 56 (21) |
| LSCS (spondylolisthesis) | 21 (8) |
| Thoracic-lumbar compression fracture | 19 (75) |
| Cervical OPLL | 6 (2) |
| Pyogenic spondylitis | 5 (2) |
| Others | 23 (9) |
| Cervical | 74 (28) |
| Thoracic | 13 (5) |
| Lumbar | 175 (67) |
Abbreviations: LSCS, lumbar spinal canal stenosis; OPLL, ossification of the posterior longitudinal ligament.
Details of Perioperative Complications (n = 75) and Major Complications (n = 33).
| Complication | No. of Cases |
|---|---|
| Intraoperative complication (n = 16) | |
| Screw malposition | 8 |
| Dural tear | 5 |
| Root injury | 2 |
| Peritoneal injury | 1 |
| Postoperative complication (n = 59) | |
| Delirium | 15 |
| Epidural hemorrhagea | 7 |
| Surgical site infectiona | 7 |
| Urinary infectiona | 6 |
| Cerebral infarctiona | 3 |
| Transient muscle weakness | 3 |
| Renal dysfunctiona | 2 |
| C5 palsy | 2 |
| Systemic edemaa | 2 |
| Liver dysfunctiona | 2 |
| Respiration disordera | 2 |
| Acute myocardial infarctiona | 1 |
| Drug rash | 1 |
| Arrhythmia | 1 |
| Anginaa | 1 |
| Hypotension | 1 |
| Infected with flu virus | 1 |
| Crural neuralgia | 1 |
| Adjacent vertebral fracture | 1 |
aIndicates a major complication (n=33).
Relationships Between Surgical Lesions and Complications.
| Surgical Lesion | Perioperative Complications (n = 75) | Major Complications (n = 33) | ||||
|---|---|---|---|---|---|---|
| Patients | Rate (%) |
| Patients | Rate (%) |
| |
| Cervical | 24 | 35 | n.s. | 12 | 17 | n.s. |
| Thoracic | 6 | 43 | 2 | 14 | ||
| Lumbar | 45 | 25 | 19 | 11 | ||
Abbreviation: n.s., not significant.
Univariate Analysis of Risk for Perioperative and Major Complication (n = 75).
| Perioperative Complication (n = 75) | Major Complication (n = 33) | |||
|---|---|---|---|---|
| Variable | HR (95% CI) |
| HR (95% CI) |
|
| Demographic | ||||
| >85 years of age | 1.159 (1.017-1.320) | .027a | 1.153 (0.974-1.366) | .099 |
| Female | 0.848 (0.428-1.679) | .636 | 0.783 (0.316-1.939) | .597 |
| Previous spinal surgery | 0.913 (0.397-2.096) | .829 | 0.942 (0.324-2.736) | .912 |
| Body mass index | 1.006 (0.946-1.070) | .854 | 0.952 (0.883-1.026) | .198 |
| Disease duration | 1.008 (0.945-1.074) | .816 | 0.991 (0.892-1.100) | .858 |
| Smoking status | 0.624 (0.048-8.113) | .719 | 0.345 (0.019-6.271) | .472 |
| Drug use | ||||
| NSAIDs | 0.732 (0.384-1.396) | .343 | 0.662 (0.281-1.560) | .345 |
| Opioids | 0.852 (0.233-3.116) | .808 | 0.283 (0.069-1159) | .079 |
| Osteoporosis agents | 0.553 (0.258-1.183) | .127 | 0.956 (0.358-2.551) | .928 |
| Anti-coagulants | 2.138 (0.910-5.020) | .081 | 4.338 (1.173-16.035) | .028a |
| Comorbidity | ||||
| Hypertension | 1.025 (0.540-1.948) | .939 | 1.028 (0.437-2.421) | .950 |
| Preexisting neoplasm | 0.605 (0.270-1.354) | .221 | 0.545 (0.192-1.548) | .254 |
| Diabetes | 0.463 (0.198-1.082) | .076 | 3.246 (1.149-9.174) | .026a |
| Cerebrovascular disease | 0.258 (0.084-1.082) | .018a | 0.334 (0.086-1.299) | .113 |
| Intraoperative factor | ||||
| Operative time (≥180 min) | 1.005 (1.000-1.009) | .046a | 4.329 (1.329-14.08) | .015a |
| Estimated blood loss (≥500 g) | 5.029 (2.438-10.18) | .001a | 1.599 (0.642-3.982) | .313 |
| Use instrumentation | 0.783 (0.355-1.725) | .544 | 0.397 (0.128-1.001) | .109 |
Abbreviations: HR, hazard ratio; NSAIDs, nonsteroidal anti-inflammatory drugs.
aIndicates significant difference (P < .05).
Multivariate Analysis of Risk for Perioperative and Major Complication (n = 33).
| Perioperative Complication (n = 75) | Major Complication (n = 33) | |||
|---|---|---|---|---|
| Variable | HR (95% CI) |
| HR (95% CI) |
|
| Demographic | ||||
| >85 years of age | 1.007 (1.001-1.009) | .025a | ||
| Intraoperative factor | ||||
| Operative time (≥180 min) | 2.780 (1.317-5.917) | .007a | ||
| Estimated blood loss (≥500 g) | 3.076 (1.425-6.641) | .004a | ||
Abbreviation: HR, hazard ratio.
aIndicates significant difference (P < .05).